Intelligent Bio Solutions Inc. (INBS)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
2. 11
-0.09
-4.0455%
$
1.39M Market Cap
- P/E Ratio
- Div Yield
85,400 Volume
-1.01 Eps
$ 2.2
Previous Close 
Want to track INBS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
INBS Stock Surges 132.4% on New Manufacturing Partnership
Intelligent Bio Solutions' stock jumps after a new manufacturing partnership aimed at cutting costs, boosting margins and scaling production ahead of U.S. expansion.
Zacks | 6 months ago
INBS Stock May Rise on SMARTOX Partnership Expanding Forensic Reach
Intelligent Bio Solutions collaborates with SMARTOX to expand U.S. forensic reach, boosting its drug test tech and eyeing FDA clearance for growth.
Zacks | 1 year ago
Intelligent Bio Solutions Stock Drops Despite Key U.S. Patent Win
INBS secures a key U.S. patent, strengthening its IP protection and paving the way for 2025 market entry with innovative biometric technology.
Zacks | 1 year ago
INBS Stock Declines Despite Positive Results of Pharmacokinetic Study
Intelligent Bio Solutions unveils strong initial results for its PK study, which is important for FDA submission of its Intelligent Fingerprinting Drug Screening System.
Zacks | 1 year ago
